Cite
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
MLA
Bulten, Wouter, et al. “Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer: The PANDA Challenge.” Nature Medicine, vol. 28, no. 1, Jan. 2022, pp. 154–63. EBSCOhost, https://doi.org/10.1038/s41591-021-01620-2.
APA
Bulten, W., Kartasalo, K., Chen, P.-H. C., Ström, P., Pinckaers, H., Nagpal, K., Cai, Y., Steiner, D. F., van Boven, H., Vink, R., Hulsbergen-van de Kaa, C., van der Laak, J., Amin, M. B., Evans, A. J., van der Kwast, T., Allan, R., Humphrey, P. A., Grönberg, H., Samaratunga, H., … Eklund, M. (2022). Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nature Medicine, 28(1), 154–163. https://doi.org/10.1038/s41591-021-01620-2
Chicago
Bulten, Wouter, Kimmo Kartasalo, Po-Hsuan Cameron Chen, Peter Ström, Hans Pinckaers, Kunal Nagpal, Yuannan Cai, et al. 2022. “Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer: The PANDA Challenge.” Nature Medicine 28 (1): 154–63. doi:10.1038/s41591-021-01620-2.